Evan Loh

Evan Loh is a declared insider at 2 companies; the most frequent names are Paratek Pharmaceuticals, Inc. and Eiger BioPharmaceuticals, Inc. The record holds 65 filings, for trades running from 30 October 2014 to 21 September 2023.

On the open market, the record shows 3 purchases worth €91k and 33 sales worth €2.3M. Netting one side against the other leaves €2.2M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 24 share grants and 2 option exercises. 2023 to date brings no purchases and 1 sale.

The median purchase comes to €22k.

The latest filing, published on 21 September 2023, reports a transaction in Paratek Pharmaceuticals, Inc. The last insider purchase was made public on 14 December 2015, 3,982 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.